The global immuno oncology assays market, valued at USD 4.76 billion in 2023, is projected to grow at a compound annual growth rate (CAGR) of 6.25% through 2029. Driven by government initiatives, innovations in immuno-oncology research, and increasing demand for personalized cancer treatment solutions, this market is witnessing significant expansion. Immuno-oncology assays play a critical role...